Nuveen Asset Management, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,357,421
-26.6%
230,592
-20.0%
0.00%
-33.3%
Q2 2023$8,666,478
+55924.8%
288,306
-32.5%
0.00%
-50.0%
Q1 2023$15,469
+3.5%
426,980
+1.9%
0.01%0.0%
Q4 2022$14,942
-99.9%
418,895
+12.2%
0.01%
+20.0%
Q3 2022$12,643,000
+23.3%
373,509
+5.3%
0.01%
+25.0%
Q2 2022$10,254,000
-36.0%
354,559
-31.1%
0.00%
-20.0%
Q1 2022$16,034,000
-23.9%
514,392
-32.0%
0.01%
-16.7%
Q4 2021$21,057,000
+2.0%
756,631
+0.0%
0.01%0.0%
Q3 2021$20,635,000
+43.8%
756,432
+62.3%
0.01%
+50.0%
Q2 2021$14,351,000
+87.0%
466,073
+59.0%
0.00%
+100.0%
Q1 2021$7,676,000
+4.4%
293,198
+0.3%
0.00%0.0%
Q4 2020$7,356,000
+19.0%
292,374
-1.5%
0.00%0.0%
Q3 2020$6,183,000
-20.8%
296,690
-9.8%
0.00%
-33.3%
Q2 2020$7,809,000
+37.4%
328,797
+4.1%
0.00%0.0%
Q1 2020$5,682,000
-20.0%
315,854
+5.5%
0.00%0.0%
Q4 2019$7,103,000
-59.3%
299,423
-52.8%
0.00%
-57.1%
Q3 2019$17,436,000
+69.6%
634,491
+104.3%
0.01%
+75.0%
Q2 2019$10,278,000
+2347.1%
310,612
+2491.0%
0.00%
+100.0%
Q1 2019$420,000
+64.7%
11,988
+56.3%
0.00%0.0%
Q4 2018$255,000
-62.4%
7,669
-43.0%
0.00%
-50.0%
Q3 2018$678,000
-60.2%
13,465
-52.7%
0.00%
-63.6%
Q2 2018$1,704,000
+73.7%
28,464
+32.9%
0.01%
+83.3%
Q1 2018$981,000
+54.7%
21,413
-14.7%
0.01%
+100.0%
Q4 2016$634,00025,1050.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders